Eradicating disease: Scientists trace and identify origin of smallpox-vaccine strains used in Civil War
PHILADELPHIA, July 16, 2020 — Scientists and historians working at the Mütter Museum’s Mütter Research Institute, McMaster University, and the University of Sydney have pieced together centuries-old virus genomes that were used as vaccination strains during and after the American Civil War, ultimately leading to the eradication of smallpox.
Smallpox was one of the most devastating viral diseases ever to strike humankind, killing about three out of every 10 people who were infected with children often hit hardest. Those who survived were frequently disabled, blind or disfigured.
To date, the smallpox-eradication campaign remains the most successful ever attempted. Earlier this summer, while we awaited a much needed vaccine for COVID-19 (May 2020), the World Health Organization ‘celebrated’ the 40th anniversary of the eradication of smallpox. The success of the smallpox-vaccination campaign and the findings of these scientists suggest that other vaccines may be waiting to be discovered among the viral relatives of today’s influenza and coronaviruses.
The concept of widespread vaccination dates back to 1796, when English physician Edward Jenner, known for his remarkable contributions to medicine, observed that exposure to a milder illness thought to be transferred from cows with a similar pox-like illness on their udders (called cowpox), to milkmaids, offered protection against future exposure to smallpox outbreaks.
The method and source material used for early smallpox-vaccinations remained unstandardized for over a century. While this “cowpox” is often referenced as the source of the first vaccination, little had been known about the specific origins and diversity of the virus strains used in early smallpox vaccination programs
For their study, outlined in the journal Genome Biology, the researchers used sophisticated techniques developed at the McMaster Ancient DNA Centre to reconstruct and analyze the genomes of virus fragments recovered from vaccination kits used during the Civil War era.
The kits, part of a medical collection at the Mütter Museum of the College of Physicians of Philadelphia, contained lancets and small glass plates for mixing fluid for vaccines that had been collected from blisters of deliberately infected subjects, and tin boxes with sliding lids to contain scab material.
The techniques used in this paper resulted in the successful recovery of viral molecules from both organic sources, such as scab material, but also from the non-destructive sampling of inorganic materials, such as tin boxes and glass slides, that had no evidence of organic residues. This finding opens a new possible field of study into medical history through the non-destructive examination of materials previously associated with biological samples.
The researchers were able to determine that in the 1860s and 1870s, medical practitioners in Philadelphia were using a vaccinia virus strain that was being propagated in female subjects of European maternal ancestry. The milder relative of the deadly smallpox pathogen was introduced into the body, usually by applying pus or scabs to a scratch or cut in the skin, where it helped recipients develop immunity to smallpox.
One of the overriding concerns about vaccine design, is how close – from an evolutionary standpoint – the vaccine strain needs to be the one causing disease to be effective, that is to prevent illness. Here, interestingly the vaccinia strains used for vaccination are in fact very distantly related to the virus that causes smallpox. The slow mutation rate of orthopox viruses (of which both vaccinia and variola are members) likely allows for this ‘distant’ protection.
“Understanding the history, the evolution, and the ways in which these viruses can function as vaccines is hugely important in contemporary times,” says evolutionary geneticist Hendrik Poinar, who is director of the McMaster Ancient DNA Centre, where the work was done, and a principal investigator at the university’s Michael G. DeGroote Institute for Infectious Disease Research.
“This work points to the importance of looking at the diversity of these vaccine strains found out in the wild. We don’t know how many could provide cross protection from a wide range of viruses, such as flus or coronaviruses,” he says.
“Vaccination is a wonderful process with a rich medical history that we should celebrate,” says Ana Duggan, a former postdoc in the Department of Anthropology at McMaster and currently a Research Biologist at the Public Healthy Agency of Canada who was lead researcher on the study. “Medical museums are these incredible repositories of our past and of our collective history. With the tools described herein we can begin to interrogate how sources, procedures and techniques changed through time.
